Sector: Pharmaceuticals & Biotechnology - Healthcare
BSE Code: 511509
NSE Symbol: VIVOBIOT
ISIN: INE380K01017
⚠️ Fire Hits Vivo Bio Tech Research Facility; No Injuries Reported - Fire broke out during early hours Tuesday, October 13, 2026, at company's research facility - No injuries or casualties arising from the incident - Fire brought under control - Building infrastructure, lab rooms, plant and machin…
Vivo Bio Tech reports NIL physical share re-lodgements in September 2026 📊 - Vivo Bio Tech submits re-lodgement report to BSE for period ended September, 2026 - Re-lodgement requests received in September, 2026: NIL - Re-lodgement requests processed in September, 2026: NIL - Re-lodgement requests…
Vivo Bio Tech: No Share Transfer Requests in August 2026 📄 - Share transfer requests for August 2026: nil - Average processing time: NA
📄 Vivo Bio Tech Annual Report FY 2025-26 Released – AGM on 30 Sep via VC - Annual Report for FY 2025-26 dispatched to shareholders without registered email. - Annual Report available on company website and RTA website. - 39th AGM on Wednesday, 30th September 2026 at 03:00 PM via VC/OAVM.
Vivo Bio Tech: 6.27 Lakh Equity Warrants Expire Unconverted ⏳ - 6,27,409 Convertible Equity Warrants have expired due to non-exercise. - The warrants were part of a total preferential issue of 25,00,000 warrants. - They were allotted to Dwight Technologies Private Limited on February 24, 2025. - T…
📄 Vivo Bio Tech: 483 Convertible Equity Warrants Expire Unexercised - 483 Convertible Equity Warrants expired due to non-exercise before the 18-month tenure completion. - Total warrants issued: 26,00,000 (Twenty Six Lakhs) on a preferential basis. - Issue price: ₹45 per warrant (Face Value ₹10 + …
Vivo Bio Tech Shareholders Cast Votes: Key Appointments & Transactions Approved ✅ - Shareholders approved all three resolutions from a Postal Ballot concluded on July 14, 2026. - Resolution 1: Re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director passed with 99.95% of valid votes (5,29…
📊 Vivo Bio Tech Q1 2026: Revenue Up 14%, But Profits Fall Sharply - Consolidated revenue rose to Rs. 1,427.97 lacs in Q1 2026 from Rs. 1,251.16 lacs in Q1 2025, up ~14.1%. - Standalone revenue increased to Rs. 1,413.94 lacs from Rs. 1,241.86 lacs, up ~13.9%. - Consolidated net profit after tax de…
📅 Vivo Bio Tech Ltd Q1 FY27 Results: Board Meeting Scheduled for July 13 - Unaudited Standalone & Consolidated Financial Results for Q1 ended June 30, 2026 will be considered and approved. - Trading window is closed for Directors, Promoters, Designated Employees, and Specified Connected Persons u…
🚨 Leadership Update at Vivo Bio Tech: New Company Secretary Appointed - Board meeting held from 4:00 P.M. to 4:20 P.M. - Mr. A V Kiran resigns as Company Secretary & Compliance Officer effective June 24, 2026. - Mr. Bhavish Vijayvargiya (Membership No. ACS 77631) appointed as new Company Secretar…
🚨 Leadership Update at Vivo Bio Tech: New Company Secretary Appointed - Mr. A V Kiran ceases to be Company Secretary and Compliance Officer from June 24, 2026. - Mr. Bhavish Vijayvargiya appointed as the new Company Secretary & Compliance Officer. - Mr. Vijayvargiya will oversee materiality asses…
🔁 Leadership Shift at Vivo Bio Tech: New Company Secretary Appointed - Mr. A V Kiran resigned as Company Secretary & Compliance Officer effective June 24, 2026. - Mr. Bhavish Vijayvargiya appointed as the new Company Secretary & Compliance Officer from the same date. - Mr. Vijayvargiya is an Asso…
🔍 CorporateUpdate: Promoter Group Exits Stake in Vivo Bio Tech – Key Details Promoter Group (Shri Shri Resorts Pvt Ltd) sold 67,000 shares (0.30% of total capital) on June 23, 2026 via open market. Pre-sale holding: 67,000 shares (0.22% of diluted capital). Post-sale: Nil. Total equity share ca…
Vivo Bio Tech Seeks Shareholder Approval for Key Leadership & Strategic Moves 📋 - Re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director (₹1,00,000/month) for 5 years from 2026. courses - Appointment of Mrs. Madhavi Latha Kompella as Advisor for Strategy & Business Development (₹15,00,…
📉 Major Stake Reduction by Vivo Bio Tech’s Promoter Group - M/s. Shri Shri Resorts Private Limited (promoter group) sold 10,00,000 equity shares on June 08, 2026 via On Market Sale. - Pre-sale holding: 10,67,000 shares (4.81% of total voting capital, 3.56% diluted). - Post-sale holding: 67,000 sh…
📊 Vivo Bio Tech Ltd Share Transfer Update: Zero Re-lodgement Requests in May 2026 - Vivo Bio Tech submitted a regulatory report on physical share transfer re-lodgement requests. - M/s. Aarthi Consultants Private Limited prepared the report. - For May 2026, there were zero requests received, proce…
📊 Vivo Bio Tech FY2026 Results: Revenue Up, But Challenges Persist - Board of Directors approved Audited Standalone & Consolidated Financial Results for Q4 and year ended March 31, 2026. - Reappointment of Mr. Kalyan Ram Mangipudi as Whole-time Director for 5 years from July 29, 2026, subject to …
📅 Vivo Bio Tech Ltd Reschedules Board Meeting | Key Updates Inside - Board Meeting rescheduled from May 29 to May 30, 2026. - Meeting to review Audited Standalone & Consolidated Financial Results for Q4 and Year ended March 31, 2026. - Proposal to amalgamate Shri Shri Resorts Private Limited with…
📅 Vivo Bio Tech Ltd Board Meeting Update: Key Decisions Ahead - Board meeting scheduled for May 29, 2026. - Agenda includes approval of Audited Standalone & Consolidated Financial Results for Q4 and FY ending March 31, 2026. - Consideration of amalgamation with Shri Shri Resorts Private Limited. …
📌 Vivo Bio Tech Ltd’s Compliance Highlights: A Year of Seamless Governance - Submitted Annual Secretarial Compliance Report for FY ending March 31, 2026. - Fully compliant with SEBI Regulations (Listing Obligations, Disclosures). - No deviations, violations, or penalties reported. - All directors…